Clarus Therapeutics Holdings Inc
NASDAQ:CRXT 1:54:27 PM EDT
Market Cap (Intraday) | 20.66M |
Current PE | N/A |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | $0.43 |
50-Day MA | $0.98 |
200-Day MA | N/A |
Clarus Therapeutics Holdings Inc Stock, NASDAQ:CRXT
555 Skokie Boulevard, Suite 340, Northbrook, Illinois 60062
United States of America
Phone: +1.847.562.4300
Number of Employees:
Description
Clarus Therapeutics Holdings, Inc. is a pharmaceutical company, which engages in developing androgen and metabolic therapies for men and women, including potential therapies for orphan indications. The company was founded in 2004 and is headquartered in Northbrook, IL.